Keywords: AKI, Acute kidney injury; BAK, Bioartificial kidney; BRECS, Bioartificial renal epithelial cell system; EP, Enhanced propagation; ESRD, End-stage renal disease; FDA, Food and Drug Administration; IL, Interleukin; IND, Investigational new drug; MOF, Multio
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Drugs, Devices, and the FDA: Part 1 : An Overview of Approval Processes for Drugs
Keywords: drug approval; FDA; investigational new drugCDER, Center for Drug Evaluation and Research; EIND, emergency investigational new drug; FDA, U.S. Food and Drug Administration; IND, investigational new drug; NDA, new drug application
Arthritis gene therapy and its tortuous path into the clinic
Keywords: AAV, Adeno-associated virus; FDA, Food and drug administration; GFP, Green fluorescent protein; IFN-b, Interferon-beta; IL-1, Interleukin-1; IL-1Ra, Interleukin-1 receptor antagonist; IND, Investigational new drug; MCP, Metacarpophalangeal; OA, Osteoarthr
Why are there no proven therapies for genetic mitochondrial diseases?
Keywords: CoQ10, coenzyme Q10; CLA, congenital Lactic Acidosis; DCA, dichloroacetate; EP, Exceptional Parent; FDA, Food and Drug Administration; IND, investigational new drug; MMA, Mercy Medical Airlift; mtDNA, mitochondrial DNA; MELAS, mitochondrial encephalomyopa
Phase I/II Examination of Transurethral Ethanol Ablation of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Keywords: transurethral resection of prostate; prostatic hyperplasia; ethanol; injectionsAE, adverse event; BPH, benign prostatic hyperplasia; BPH II, benign prostatic hyperplasia impact index; FDA, Food and Drug Administration; IND, investigational new drug; I-PSS
Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays
Keywords: ATP, adenosine 5′ triphosphate; BSA, bovine serum albumin; CV, coefficient of variation; FDA, Food and Drug Administration; HMG-CoA reductase, hydroxy methyl glutaryl Coenzyme A reductase; HTS, high throughput screening; IND, investigational new drug; NAD
Drug targeting of dysregulated transcription in Huntington's disease
Keywords: HD, Huntington's Disease; Htt, Huntingtin; IND, Investigational New Drug; HAT, Histone Acetyl Transferase; HDAC, Histone deacetylase; SAHA, Suberoylanilide hydroxamic acid; Sir2, Silent Information Regulator (Sirtuin); SirT1, Sirtuin 1; SirT2, Sirtuin 2;